
A recent study involving 427,480 adults from the UK Biobank has found a concerning link between the use of calcium channel blockers (CCBs) and an increased risk of glaucoma. After adjusting for various factors, CCB users had a 39% higher likelihood of developing glaucoma than non-users. Additionally, CCB use was associated with thinner inner retinal layer thicknesses, providing structural evidence for this association. Interestingly, this link did not appear to be related to intraocular pressure (IOP), suggesting an IOP-independent mechanism in developing glaucomatous neurodegeneration. The study urges consideration of CCB replacement or withdrawal if glaucoma progresses despite treatment.
Like
Save
Share